This suggests that butyrate-producing L. salivarius may be considered as a potential treatment for obesity in infants by reducing inflammatory cytokines and regulating leptin/insulin levels, but this requires further investigations and elucidation through future RCTs. The gene discussed is LEP; the disease is obesity disorder.